Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH

(2013) Francesco Blasi et al.   RESPIRATORY RESEARCH

Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety

(2012) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus

(2012) Muhammad Sajid Hamid Akash et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus

(2012) Muhammad Sajid Hamid Akash et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Association Between Time to Clinical Stability and Outcomes After Discharge in Hospitalized Patients With Community-Acquired Pneumonia

(2011) Stefano Aliberti et al.   CHEST

Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis

(2011) S. R. Ott et al.   EUROPEAN RESPIRATORY JOURNAL

Burden of Community-Acquired Pneumonia in North American Adults

(2010) Thomas M. File et al.   POSTGRADUATE MEDICINE

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia

(2009) S. Aliberti et al.   EUROPEAN RESPIRATORY JOURNAL

Impact of Guidelines on Outcome: The Evidence

(2009) Raquel Martínez et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE